- Home
- ECOR vs INMB Comparison
ECOR vs INMB Comparison
Compare ECOR & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECOR | INMB |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 40.4M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ECOR | INMB |
|---|---|---|
| Price | $6.43 | $1.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $18.00 | $5.40 |
| AVG Volume (30 Days) | 45.2K | ★ 217.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,032,000.00 | $50,000.00 |
| Revenue This Year | $33.60 | N/A |
| Revenue Next Year | $30.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 27.20 | ★ 257.14 |
| 52 Week Low | $4.16 | $1.09 |
| 52 Week High | $8.30 | $11.64 |
Technical Indicators
Market Signals| Indicator | ECOR | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 63.10 |
| Support Level | $4.61 | $1.38 |
| Resistance Level | $6.61 | $1.71 |
| Average True Range (ATR) | 0.53 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 42.28 | 68.79 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.